Skip to content

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, Eef L. Theunissen, Friederike Holze, Matthias E. Liechti, Amanda Feilding, Johannes G. Ramaekers, Kim P. C. Kuypers

European Neuropsychopharmacology October 17, 2020 DOI: 10.1016/j.euroneuro.2020.10.002 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Placebo-controlled within-subject study Peer reviewed
Sample size 24
Population Healthy participants
Intervention LSD
Dose 5, 10, and 20 mcg
Duration 6 h after administration
Topics Anxiety LSD
Keywords Mood Vigilance psychology Cognition Placebo Psychomotor learning Arousal Continuous performance task Affect linguistics Clinical psychology Audiology
Citations 121
Key points Low doses of LSD (5 to 20 mcg) produce selective beneficial effects on mood and cognition, with the minimal effective dose being 5 mcg and the most apparent effects at 20 mcg.

Abstract

There is a popular interest in microdosing with psychedelics such as LSD. This practice of using one-tenth of a full psychedelic dose according to a specific dosing schedule, anecdotally enhances mood and performance. Nonetheless, controlled research on the efficacy of microdosing is scarce. The main objective of the present dose-finding study was to determine the minimal dose of LSD needed to affect mood and cognition. A placebo-controlled within-subject study including 24 healthy participants, was conducted to assess the acute effects of three LSD doses (5, 10, and 20 mcg) on measures of cognition, mood, and subjective experience, up until 6 h after administration. Cognition and subjective experience were assessed using the Psychomotor Vigilance Task, Digit Symbol Substitution Test, Cognitive Control Task, Profile of Mood States, and 5-Dimensional Altered States of Consciousness rating scale. LSD showed positive effects in the majority of observations by increasing positive mood (20 mcg), friendliness (5, 20 mcg), arousal (5 mcg), and decreasing attentional lapses (5, 20 mcg). Negative effects manifested as an increase in confusion (20 mcg) and anxiety (5, 20 mcg). Psychedelic-induced changes in waking consciousness were also present (10, 20 mcg). Overall, the present study demonstrated selective, beneficial effects of low doses of LSD on mood and cognition in the majority of observations. The minimal LSD dose at which subjective and performance effects are notable is 5 mcg and the most apparent effects were visible after 20 mcg.

Comparable studies

Other randomized controlled trials on LSD for anxiety, most cited first.

Study Year Design Participants
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Patients with anxiety associated with life-threatening diseases 2014 Randomized controlled trial n = 12
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers Healthy male volunteers with prior experience using ayahuasca 2001 Single-blind crossover placebo-controlled clinical trial n = 6
Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Patients who experienced anxiety with or without association with a life-threatening... 2023 Randomized controlled trial n = 42
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality Healthy, mostly hallucinogen-naive 25- to 65-year-old volunteers (20 men, 20 women) 2016 Randomized controlled trial n = 40
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers Healthy volunteers 2020 Randomized controlled trial n = 24

Explore topics

By condition and practice